Category — Healthcare
Warsaw, Indiana-based medical device company Zimmer Biomet announced a multi-year collaboration with the Indo-U.K. Institutes of Health that will increase the capacity of India’s healthcare infrastructure. The Institute will help improve the delivery of healthcare across India by training more than 1,000 orthopedic surgeons annually on the latest orthopedic procedures and the safe and effective use of Zimmer Biomet medical technologies.
The first phase of the collaboration involves the establishment of the Zimmer Biomet Institute of India, a 30,000 square foot medical training and education facility on the campus of King’s College Hospital in Amaravati, in the eastern state of Andhra Pradesh. Zimmer Biomet plans on investing $5 million in this facility over three years, starting in 2017. The King’s College Hospital in Amaravati is scheduled to break ground later this year, and is expected to create jobs for 2,500 nurses and 500 physicians.
Beckersspine reports that the Indo UK Institutes of Health, along with the United Kingdom’s National Health Service, is also planning on establishing 11 “medicities” across India, which will include hospitals, medical schools and training centers. The initiative is backed by the U.K. and Indian prime ministers and governmental institutions, including U.K. Trade and Investment and Healthcare UK.
August 7, 2016 No Comments
BioSpectrum reports that the government of India has approved the establishment of a regional center for biotechnology in the National Capital Region. Under the auspices of United Nations Educational, Scientific and Cultural Organization (UNESCO) , the center will be an institution of national importance which will provide teaching and research facilities in biotechnology and related fields, facilitate transfer of technology and knowledge in the SAARC region and Asia, and create a hub of biotechnology expertise, and promoting cooperation at the international level.
The country’s Union Minister of Science & Technology and Earth Sciences, Dr. Harshvardhan said the Indian biotech sector had grown threefold and that the country had immense potential in terms of research and development facilities, knowledge, skills, and cost effectiveness to emerge as a global player. “This institution will help us train professionals from the whole country, and will serve as a mentor institution helping all bio-technology institutions in the country,” he added.
August 7, 2016 No Comments
Waltham, Massachusetts-based global diagnostic device and service provider, Alere Inc., announced the opening of a diagnostics manufacturing facility in Manesar, in the northern state of Haryana, which will produce rapid tests for the detection of infectious diseases including Malaria, Dengue and HIV and export them across the Asia Pacific region. The 180,000 square foot factory, in which the company has currently invested $25 million, will initially employ a staff of y 300 people; it can double its capacity as needed.
Namal Nawana, CEO & President, Alere Inc., said, ”Alere’s new facility will support the goals of our ‘Make in India’ initiative, which seeks to transform India into a global manufacturing hub. Efforts to foster and expand India’s medical device sector are important not only to our economic growth, but also to improve the health of the people of India. The new state-of-the-art facility will not only help us meet the needs of the burgeoning domestic market but also help us cater to the APAC market.”
BioSpectrum reports that Alere Inc., aims to achieve its target of $ 149 million (Rs. 1,000 crore) over the next 3 years equipped with portfolio innovative Point-Of-Care-Testing diagnostic products that will focus on improving health outcomes. The company will continue to focus on cardiometabolic diseases, infectious diseases and toxicology solutions in India by providing affordable, sensitive, specific, user-friendly, devices for disease control & management.
August 6, 2016 No Comments
The Wall Street Journal cites the Naukri Job Speak Index which records an increase of 22% in hiring activity from a year earlier. Since May this year, hiring activity was up 6.8% the report said.
The index is measured on the basis of job listings added to the site every month. The company says more than 48,000 clients are using the website.
Sectors reporting hiring gains:
- Telecommunications recorded a 44% year-over-year increase in June
- Outsourcing services rose 42%
- Healthcare sector saw a 37% increase in new job activity
- Software services increased 19%
- Auto and auto ancillary recorded a 14% gain
Sectors reporting hiring losses:
- Construction and engineering sector fell 15%
- Real estate recorded a hiring fall of 9%
- Oil and gas hiring dipped 3%
Banking, financial services and insurance, and pharmaceuticals sectors were stagnant.
July 25, 2016 No Comments
Keeping in mind the ‘Make in India’ initiative, India’s Federal government has decided to comprehensively review and revise the existing 76-year old drug laws on two important features: 1) to facilitate the ease of doing business, and 2) to substantially enhance the quality and efficacy of its products. The rewrite of the laws will take into account the regulation of biologics, regenerative medicines and clinical trials.
The Ministry of Health and Family Welfare has framed separate rules under the existing Act for regulating medical devices.The ministry is also working to bring about separate legislations for regulating medical devices and drugs and cosmetics.
A draft of the revised drugs law is expected to be ready in two months, top drug controller G.N. Singh told Reuters last week. “We thought it was better to revise the law than to put more bandages on it,” Singh said. He also mentioned that the government had requested regulators from the U.S. and Europe for input.
Meanwhile, the medical devices industry has welcomed the Cabinet decision. “AdvaMed appreciates the government of India’s efforts over the years to press forward with legislation that would create separate and appropriate regulations for medical devices,” said a statement issued by AdvaMed India, a forum of medical devices manufacturers.
“We view the withdrawal of the Drugs and Cosmetics (Amendment) Bill, 2013 as an opportunity to start fresh and consult with relevant stakeholders to draft new and globally harmonized legislation that would once and for all carve out distinct regulations for medical devices. This step is critical to the growth of the industry and — equally as important — to ensure that patients have access to innovative and lifesaving technologies,” added Advamed.
June 23, 2016 No Comments